Press "esc" to clear
Go to Advanced Search

Showing results

2130 of 3263

Article ID: 698676

Traveling Safely with Heart Disease

Beth Israel Deaconess Medical Center

Dr. Eli Gelfand, Chief of the Outpatient Cardiology Clinic at Beth Israel Deaconess Medical Center, is available for interview to discuss traveling safely with heart disease.

Released:
7-Aug-2018 11:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 698638

Announcing the TCT 2018 Late-Breaking Trials

Cardiovascular Research Foundation (CRF)

The Cardiovascular Research Foundation (CRF) has announced the 15 late-breaking trials and 12 late-breaking clinical science presentations that will be reported at the Transcatheter Cardiovascular Therapeutics (TCT) 2018 scientific symposium. TCT, the world’s premier educational meeting specializing in interventional cardiovascular medicine, will take place September 21 – 25, 2018 at the San Diego Convention Center in San Diego, California.

Released:
7-Aug-2018 10:35 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
rawpixel-577480-unsplash.jpg
  • Embargo expired:
    6-Aug-2018 4:00 PM EDT

Article ID: 698562

Health Systems in Low- and Middle-Income Countries Not Prepared to Diagnose and Treat Common Diseases

University of California, Los Angeles (UCLA), Health Sciences

Bangladesh, Haiti, Malawi, Nepal and Tanzania each has fewer than five health facilities that can properly diagnose and treat cardiovascular diseases, chronic respiratory diseases and diabetes, a new UCLA study reports.

Released:
3-Aug-2018 3:30 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
  • Embargo expired:
    6-Aug-2018 3:00 PM EDT

Article ID: 698446

Women Survive Heart Attacks Better with Women Doctors

Washington University in St. Louis

A review of nearly 582,000 heart attack cases over 19 years showed female patients had a significantly higher survival rate when a woman treated them in the ER, according to research from faculty at the University of Minnesota-Twin Cities, Washington University in St. Louis and Harvard.

Released:
2-Aug-2018 8:00 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
RS20200_GaneshHalade-13-scr_edited.jpg

Article ID: 698613

Doxorubicin disrupts the immune system to cause heart toxicity

University of Alabama at Birmingham

Researchers have found an important contributor to heart pathology caused by the cancer drug doxorubicin — disruption of metabolism that controls immune responses in the spleen and heart. This allows chronic, non-resolving inflammation that leads to advanced heart failure.

Released:
6-Aug-2018 2:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
SmartWristbandFigure2.jpg

Article ID: 698590

Smart Wristband With Wireless Link to Smartphones Could Monitor Health, Environmental Exposures

Rutgers University-New Brunswick

Rutgers University–New Brunswick engineers have created a smart wristband with a wireless connection to smartphones that will enable a new wave of personal health and environmental monitoring devices. Their technology, which could be added to watches and other wearable devices that monitor heart rates and physical activity, is detailed in a study published online in Microsystems & Nanoengineering.

Released:
6-Aug-2018 1:15 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
Borzio_Robert_MD_7604.jpg

Article ID: 698599

Bayshore Medical Center Welcomes Robert Borzio, M.D., Orthopedic Surgeon

Hackensack Meridian Health

Hackensack Meridian Health Bayshore Medical Center in Holmdel, NJ, is pleased to welcome Robert Borzio, M.D., to its team of physicians. Dr. Borzio is an orthopedic surgeon, providing general orthopedic care and treatment of fractures in the upper and lower extremities. He specializes in muscle sparing computer navigated total hip and knee replacement and revision hip and knee replacement.

Released:
6-Aug-2018 12:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 698600

Potential New Class of Drugs May Reduce Cardiovascular Risk by Targeting Gut Microbes

Cleveland Clinic

Cleveland Clinic researchers have designed a potential new class of drugs that may reduce cardiovascular risk by targeting a specific microbial pathway in the gut. The research, published in the September issue of Nature Medicine, was led by Stanley Hazen, M.D., Ph.D.

Released:
6-Aug-2018 11:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
burns_jane_UCSDHealth.jpg
  • Embargo expired:
    6-Aug-2018 11:00 AM EDT

Article ID: 698548

Researchers Identify Potential Diagnostic Test for Kawasaki Disease

University of California San Diego Health

For the first time, researchers at University of California San Diego School of Medicine and Imperial College London, with international collaborators, have determined that Kawasaki Disease (KD) can be accurately diagnosed on the basis of the pattern of host gene expression in whole blood. The finding could lead to a diagnostic blood test to distinguish KD from other infectious and inflammatory conditions.

Released:
3-Aug-2018 1:45 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
8-6-2018VanessaM.jpg

Article ID: 698555

Severe Preeclampsia Heart Imaging Study Reveals Roots of Cardiac Damage in Pregnant Women

Johns Hopkins Medicine

Johns Hopkins researchers say a heart imaging study of scores of pregnant women with the most severe and dangerous form of a blood pressure disorder has added to evidence that the condition — known as preeclampsia — mainly damages the heart’s ability to relax between contractions, making the organ overworked and poor at pumping blood.

Released:
6-Aug-2018 8:00 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Showing results

2130 of 3263





Chat now!